drugset / Trial / NCT06972615
Intravesical Chemotherapy in Combination With Systemic Pembrolizumab in NMIBC Unresponsive or Exposed to BCG Therapy
NaSingle-groupOpen-labelTreatment
Summary
interventional study of intravesical chemotherapy and sistemic immunotherapy in NMIBC
Timeline
- Start
- 2026-05-21
- Primary completion
- 2029-12-31
- Completion
- 2030-06-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | — | Intravenous |
| Subject | Gemcitabine | Small molecule | — | Intravenous |